Paclitaxel

Paclitaxel is a tetracyclic diterpenoid isolated first from the bark of the Pacific yew tree, Taxus brevifolia. It is a mitotic inhibitor used in cancer chemotherapy. Note that the use of the former generic name ‘taxol’ is now limited, as Taxol is a registered trade mark. Among its listed roles, it functions as a microtubule-stabilising agent, a metabolite, a human metabolite and an antineoplastic agent. It is a tetracyclic diterpenoid and a taxane diterpenoid. Functionally, it is related to baccatin III. It is grouped under the following drug class(es): Antineoplastic agents, Cytotoxics, Microtubule inhibitors, Taxanes and Terpenes. Its therapeutic use is listed as anti-cancer agents and antineoplastics. The directory classifies it as a commercial API with a natural source/manufacturing origin. Other names for this substance include Yewtaxan, Intaxel and Mitotax. Its PubChem CID is 36314.

CAS No 33069-62-4
Molecular Formula C47H51NO14
Molecular Weight 853.9 g/mol
Synonyms [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate

Frequently Asked Questions